share_log

アステラス製薬:アステラスのVYLOY(ゾルベツキシマブ-clzb)は、進行した胃がんと遺伝子組み換えがんの治療薬として米国FDAに承認されました

Astellas Pharma: Astellas’ VYLOY (zolbetuximab-clzb) Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer

JPX ·  Oct 21 07:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more